AnswersNow Completes $40M Series B to Expand BCBA-Driven, AI-Enabled Autism Therapy
RICHMOND, Va., Jan. 21, 2026 (GLOBE NEWSWIRE) -- AnswersNow, the leader in virtual Applied Behavioral Analysis (ABA) therapy, today announced...
Month: January 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025
Company Announcement Net sales of DARZALEX® in 2025 totaled USD 14,351 millionGenmab receives royalties on worldwide net sales from Johnson...
Comphya Announces Publication of CaverSTIM First-in-Man Clinical Study in BJUI and Scientific Review in Nature Urology
Peer-reviewed publications validate the scientific foundation and early clinical potential of CaverSTIM™ in restoring erectile functionLAUSANNE, Switzerland, Jan. 21, 2026...
IO Biotech Announces Exploration of Strategic Alternatives
NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf...
Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year
Improved image and data acquisition Improved image and data acquisition Philips Verida spectral CT system, angle view Philips Verida spectral...
AMSilk’s bioengineered silk protein yarns debut in Balenciaga Spring 2026 Collection
First commercially available products using AMSilk’s biotech silk protein yarnsDemonstrating a scalable, low impact alternative to conventional silk within luxury...
Angelini Pharma Announces Appointment of Sergio Marullo di Condojanni as New CEO
CEO of family company Angelini Industries will also lead the pharmaceutical company from today, bringing strong leadership experience and strategic...
Crucial Innovations Corp. Launches 4TP, a New Patient-Focused Brand of Cannabis-Based Products for Medicinal Use
4TP (“For The People”) introduces carefully cultivated CBPMs supported by transparent education and a commitment to consistent high-quality medicineLONDON, Jan....
FDA Granted Hopstem’s hNPC01 for Chronic Ischemic Stroke Approval to Enter Phase 2/3 Adaptive Pivotal Clinical Trial with Bridging Study
HOUSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Hopstem Biotechnology Inc. (hereinafter referred to as "Hopstem"), a company dedicated to the...
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR),...
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
LITTLETON, Colo., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical...
Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders
BRISBANE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company with a...
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025
Vancouver, Canada, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic
MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR),...
BioAge Announces Proposed Public Offering
EMERYVILLE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company...
Erasca Announces Proposed Public Offering of $150 Million of Common Stock
SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on...
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
SOUTH SAN FRANCISCO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today...
Edison Issues Report on Noctiluca (NCL)
London, United Kingdom--(Newsfile Corp. - January 21, 2026) - Edison issues report on Noctiluca (WSE: NCL).Noctiluca is a dynamic advanced...
CBIH Evaluates a Potential Reg A Offering of Approximately $1,000,000 to Enable Commercial Launch, Statewide Educational Expansion, and Protection of Its Patent Portfolio
Houston, Texas--(Newsfile Corp. - January 21, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on...
Women in Life Science Denmark (WiLD) expands Nordic footprint with launch of WiLD Finland
WiLD strengthens Nordic collaboration across Denmark, Finland, Norway and SwedenCOPENHAGEN, Denmark and HELSINKI, Jan. 21, 2026 /PRNewswire/ -- Women in...